Briacell Therapeutics Corp (BCTX) — Cash Flow Quality Index
Latest as of April 2024:
-2.94x
Briacell Therapeutics Corp (BCTX) has a Cash Flow Quality Index of -2.94x as of April 2024. Operating cash flow of $-6.78 Million is below net income of $2.31 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore long-term investment intensity of Briacell Therapeutics Corp to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-2.94x
Operating CF / Net Income
Operating Cash Flow
$-6.78 Million
USD
Net Income
$2.31 Million
USD
Data as of
Apr 2024
Most recent filing
Annual Cash Flow Quality Index for Briacell Therapeutics Corp (None–None)
Year-by-year earnings quality comparison for Briacell Therapeutics Corp. For live market cap and the full company financial profile, see Briacell Therapeutics Corp market cap and net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.